| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/20/2007 | EP1797897A1 Medicinal composition containing meltrin antagonist |
| 06/20/2007 | EP1797891A1 Total enteral nutritious composition |
| 06/20/2007 | EP1797887A1 Drug for diminishing increase of neutral fat in blood after meal and food containing the same |
| 06/20/2007 | EP1797878A2 Benzothiazole derivatives |
| 06/20/2007 | EP1797093A1 Novel 3-methyl-7-butinyl-xanthines, production thereof, and use thereof as medicaments |
| 06/20/2007 | EP1797046A2 Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium |
| 06/20/2007 | EP1797042A1 Indozolone derivatives as 11b-hsd1 inhibitors |
| 06/20/2007 | EP1797033A2 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof |
| 06/20/2007 | EP1796683A1 Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses |
| 06/20/2007 | EP1796671A1 Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 06/20/2007 | EP1796666A1 Methods and compositions for the treatment of hyperlipidemia |
| 06/20/2007 | EP1796657A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/20/2007 | EP1599452B1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis |
| 06/20/2007 | EP1594517B1 Compositions for the treatment of gastrointestinal disorders |
| 06/20/2007 | EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/20/2007 | EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 06/20/2007 | EP1414457B1 Chiral dinapsoline |
| 06/20/2007 | EP1413308B1 Hypoglycemic agent |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1379254B1 Use of bile acid or bile salt fatty acid conjugates |
| 06/20/2007 | EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 06/20/2007 | EP1324760B1 Creatine ester pronutrient compounds and formulations |
| 06/20/2007 | EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/20/2007 | EP1180520B1 Pyrimidine carboxylic acid derivatives |
| 06/20/2007 | CN1984649A Fat combustion accelerator |
| 06/20/2007 | CN1984647A Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
| 06/20/2007 | CN1982336A Human pancreas glucagon sample peptide-1-derivative, its production and use |
| 06/20/2007 | CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/20/2007 | CN1982299A Benzoxasine and benzothiasine derivatives and pharmaceutical composition containing the same |
| 06/20/2007 | CN1981873A Method of manufacturing micro colloidal particle and use of the same |
| 06/20/2007 | CN1981870A Invert-sugar powdery injection and its production |
| 06/20/2007 | CN1981856A Chinese medicine for treating and preventing early diabetes and nephropathy |
| 06/20/2007 | CN1981848A Extraction and use for cold-pressed concentrate composition of celery, Chinese onion and onion |
| 06/20/2007 | CN1981839A Medicine for treating diabetes and its production |
| 06/20/2007 | CN1981836A Stasis-expelling drop pills for treating coronary heart disease, angina cordis and high blood fat and thereof making method |
| 06/20/2007 | CN1981814A Use and production for mulberry leaf in treatment of diabetes |
| 06/20/2007 | CN1981789A Seabuckthorn flavonid micropills and their production |
| 06/20/2007 | CN1981777A Chinese medicinal preparation for treating cardio vascular diseases, its making method and use |
| 06/20/2007 | CN1981775A Acarbose dropping balls and their production |
| 06/20/2007 | CN1981774A Medicinal compositions |
| 06/20/2007 | CN1981772A Composition and method for decreasing concentration of low density lipoprotein cholesterol |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1981752A Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine |
| 06/20/2007 | CN1981626A Coarse-cereals gruel with cosmetic and skin-nourishing functions |
| 06/20/2007 | CN1981625A Coarse-cereals gruel with weight-los function |
| 06/20/2007 | CN1981622A Coarse-cereals gruel with blood-sugar decreasing and auxiliary treatment functions for diabetes |
| 06/20/2007 | CN1981621A Matter and method for treating or preventing fatness |
| 06/20/2007 | CN1322013C Soluble high branched glucose polymer and its producing process |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/20/2007 | CN1321673C Blood fat-eliminating medicine pill and its prepn |
| 06/20/2007 | CN1321648C Insulin sensitive-intensifying agent from plant and its preparing method and use |
| 06/20/2007 | CN1321646C Oral zinc reinforcing agent using hydrotalcite as carrier, its preparation and using method thereof |
| 06/20/2007 | CN1321644C Process for making substituted pyrazoles |
| 06/20/2007 | CN1321640C Application of benzydalysine in preparing medicine for treating diabetic peripheral neuropathy |
| 06/20/2007 | CN1321637C Chinese medicinal hypoglycemic agent and preparation thereof |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232879 complex consisting of a divalent metal cation associated with and capable of co-precipitating with such a peptide for enhancing the expression of insulin from mammalian pancreatic B-type islet cells |
| 06/19/2007 | US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| 06/19/2007 | US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives |
| 06/19/2007 | CA2283159C Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 06/19/2007 | CA2281844C Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 06/14/2007 | WO2007067964A2 Mucosal delivery of stabilized formulations of exendin |
| 06/14/2007 | WO2007067614A1 l, l, 3-TRI0X0-l, 2, 5-THIADIAZ0LIDINES AND THEIR USE AS PTP-ASES INHIBITORS |
| 06/14/2007 | WO2007067612A1 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| 06/14/2007 | WO2007067043A1 Preparation for treatment of mineral deficiency |
| 06/14/2007 | WO2007067027A1 Pharmaceutical compositions containing combined antidiabetic substances for use in type 2 diabetes mellitus |
| 06/14/2007 | WO2007066928A1 Use of the extract of caesalpinia sappan l. and compounds therefrom |
| 06/14/2007 | WO2007066655A1 Equal-containing fermentation product of soybean embryonic axis, and method for production thereof |
| 06/14/2007 | WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof |
| 06/14/2007 | WO2007066355A1 Processes for the preparation and estimation of enriched calcitriol containing extracts from cestrum diurnum and compositions thereof |
| 06/14/2007 | WO2007065948A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 06/14/2007 | WO2007065820A1 Tricyclic amide derivatives useful for treating obesity |
| 06/14/2007 | WO2007065808A2 Neuropeptide-2 receptor-agonists |
| 06/14/2007 | WO2007065539A1 Extracts of gynostemma and compositions for reducing blood lipid levels |
| 06/14/2007 | WO2007065373A1 Use of cortex prunus armeniaca l. and extracts thereof in manufacturing medicaments for treating diabetes |
| 06/14/2007 | WO2007065273A1 Mucopolysaccharidosis (mps) diagnostic methods, systems, kits and assays associated therewith |
| 06/14/2007 | WO2007047401A3 A1 adenosine receptor agonists |
| 06/14/2007 | WO2007044560A3 Modulators of atp-binding cassette transporters |
| 06/14/2007 | WO2007043294A9 Visceral fat accumulation inhibitor |
| 06/14/2007 | WO2007035372A3 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 06/14/2007 | WO2007032013A3 Compounds for improving nutritional status, cognition and survival |
| 06/14/2007 | WO2007005453A3 Compositions for treating or preventing obesity and insulin resistance disorders |
| 06/14/2007 | US20070135508 e.g. (2(2S)-(1 alpha , 5 alpha , 6 alpha )-6-N-[3-benzyl-3-azabicyclo[3.1.0]-hexyl]-2-[(1R or 1S)-3-oxocyclohexyl]-2-hydroxy-2-phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135486 antidiabetic drugs or foods; sulfonium compounds |
| 06/14/2007 | US20070135464 Antiinflammation agents |
| 06/14/2007 | US20070135402 Azetidine ring compounds and drugs comprising the same |
| 06/14/2007 | US20070135335 Therapeutic molecules |
| 06/14/2007 | US20070134735 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 06/14/2007 | US20070134300 Novel chromium (iii) alpha amino acid complexes |
| 06/14/2007 | US20070134258 Gasp1: a follistatin domain containing protein |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | CA2856436A1 Uses of myostatin antagonists |
| 06/14/2007 | CA2632719A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 06/14/2007 | CA2631850A1 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof |
| 06/14/2007 | CA2631128A1 Tricyclic amide derivatives useful for treating obesity |
| 06/14/2007 | CA2631007A1 1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as ptp-as inhibitors |
| 06/14/2007 | CA2630649A1 Neuropeptide-2 receptor-agonists |
| 06/14/2007 | CA2630624A1 Compositions and methods for increasing insulin sensitivity |
| 06/14/2007 | CA2630448A1 1,1,3-trioxo-1,2,5-thiadiazolidines and their use as ptp-ases inhibitors |